https://www.selleckchem.com/pr....oducts/rgd-arg-gly-a
The total direct costs of secondary care of COVID-19 in Europe were estimated at EUR 13.9 billion. Thus, 23.5% of the total costs accounted for treating people with diabetes. This study highlights the importance of a greater focus on prevention and adequate treatment of diabetes and the need for special attention to avoid infection with COVID-19 to the extent possible among those already diagnosed with diabetes. This study highlights the importance of a greater focus on prevention and adequate treatment of diabetes and